Zn(II) compound with blue luminescence and activity evaluation on tendon bone healing

Mixed ligand of H2ip and L assembled with Zn(NO3)2 ·6H2O under solvothermal conditions provided a novel Zn(II) compound formulated as [Zn(ip)(L)] (1, H2ip = isophthalic acid, L is 4-[4-(1H-imidazol-1-yl)phenyl]-2, 6-bis(pyridin-4-yl)pyridine). This compound’s emission performances in solid state were also explored at RT. In the biological section, the as-created complex’s application values against tendon bone healing were discussed, and the mechanism was researched simultaneously. First, activation of the Wnt signaling pathway in bone tissue was examined by real-time reverse transcription-polymerase chain reaction. Second, quantitative computed tomography was performed to measure the bone density of the animal after compound treatment.